HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NTP Touts 2010-2011 Achievements In Race To End Animal Testing

This article was originally published in The Rose Sheet

Executive Summary

Interagency Groups under NIH’s National Toxicology Program contributed to the adoption of 14 new and updated test methods to refine, reduce and replace the use of animals, and continued making strides toward global harmonization, in 2010-2011. NICEATM and ICCVAM provide a progress report.

You may also be interested in...



NTP Five-Year Plan Prioritizes Collaboration, Anticipates Tech Innovations

Interagency groups under the U.S. National Toxicology Program release their latest draft Five-Year Plan, which will push for adoption of new alternatives to animal tests and technologies to enhance methods.

L'Oreal/EPA Partnership Could Expand Non-Animal Test Strategies

L’Oreal and the U.S. EPA are collaborating to test the usefulness of the agency’s chemical-screening platform in predicting the toxicity of cosmetic substances – particularly vis-a-vis sensitive endpoints for which alternative tests currently do not exist – in advance of an EU ban on cosmetic products tested on animals.

Europe May Reduce Scope Of 2013 Ban On Animal-Tested Cosmetics

The European Commission is considering whether to limit the scope of the 2013 EU ban on cosmetics tested on animals per the Seventh Amendment to the Cosmetics Directive. A decision is expected in the first half of 2012.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel